The store will not work correctly when cookies are disabled.
rac-2-((4S,5S)-4-((1H-imidazol-4-yl)methyl)-5-methyl-4,5-dihydrothiazol-2-yl)phenol
ID: ALA4212435
PubChem CID: 145964159
Max Phase: Preclinical
Molecular Formula: C14H15N3OS
Molecular Weight: 273.36
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: C[C@@H]1SC(c2ccccc2O)=N[C@H]1Cc1c[nH]cn1
Standard InChI: InChI=1S/C14H15N3OS/c1-9-12(6-10-7-15-8-16-10)17-14(19-9)11-4-2-3-5-13(11)18/h2-5,7-9,12,18H,6H2,1H3,(H,15,16)/t9-,12-/m0/s1
Standard InChI Key: YSCNOWHLCXMNDZ-CABZTGNLSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
29.1968 -3.7254 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.0258 -3.7254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2856 -2.9375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6134 -2.4500 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
28.9433 -2.9375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1619 -2.6848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9907 -1.8769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2030 -1.6202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5856 -2.1741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7638 -2.9895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5469 -3.2405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6033 -1.3245 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.0708 -2.6862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5091 -4.3939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3297 -4.3095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8781 -4.9254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6325 -4.5916 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.5481 -3.7710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7416 -3.5978 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 2 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
5 6 1 0
7 12 1 0
3 13 1 1
2 14 1 6
14 15 1 0
15 16 2 0
16 17 1 0
17 18 1 0
18 19 2 0
19 15 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 273.36 | Molecular Weight (Monoisotopic): 273.0936 | AlogP: 2.61 | #Rotatable Bonds: 3 |
Polar Surface Area: 61.27 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.62 | CX Basic pKa: 6.53 | CX LogP: 3.06 | CX LogD: 3.01 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.90 | Np Likeness Score: 0.83 |
References
1. Lin Z, Smith MD, Concepcion GP, Haygood MG, Olivera BM, Light A, Schmidt EW.. (2017) Modulating the Serotonin Receptor Spectrum of Pulicatin Natural Products., 80 (8): [PMID:28745513] [10.1021/acs.jnatprod.7b00317] |